{
    "code": "02025755",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025755",
    "time": "2019-04-19 03:53:35",
    "許可證字號": "衛署藥輸字第025755號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "111\/11\/19",
    "發證日期": "101\/11\/19",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202575505",
    "中文品名": "易得平錠 80 毫克",
    "英文品名": "EDARBI tablets 80mg",
    "適應症": "治療高血壓",
    "劑型": "110錠劑",
    "包裝": "2-1000粒盒裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "TAK-491(AZILSARTANMEDOXOMIL(ASPOTASSIUMSALT))"
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1406701100  台灣武田藥品工業股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "F260328200  TAKEDA PHARMACEUTICAL COMPANY, LTD. (OSAKA PLANT)",
        "製造廠廠址": "17-85 JUSOHONMACHI 2-CHOME, YODOGAWA-KU, OSAKA 532-8686, JAPAN",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "6133061413  歐帕生技醫藥股份有限公司",
            "製造廠廠址": "新竹縣湖口鄉光復路1號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "包裝"
        },
        {
            "製造廠名稱": "F260328000  TAKEDA PHARMACEUTICAL COMPANY LIMITED (HIKARI PLANT)",
            "製造廠廠址": "4720, TAKEDA, MITSUI, HIKARI, YAMAGUCHI 748-8502, JAPAN",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": ""
        },
        {
            "製造廠名稱": "F462401000  AndersonBrecon Inc",
            "製造廠廠址": "4545 ASSEMBLY DRIVE, ROCKFORD, IL 61109 USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "分裝"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2408007110",
            "成分名稱": "TAK-491 (AZILSARTAN MEDOXOMIL (AS POTASSIUM SALT))",
            "含量描述": "as the free acid 80mg",
            "含量": "85.3600000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "直徑7.6mm",
        "特殊劑型": "",
        "顏色": "白色至接近白色",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "圓扁形",
        "標記一": "ASL",
        "標記二": "80"
    },
    "藥物辨識外觀圖片": [
        {
            "title": "blistering-102-06-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025755&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "PI_Edarbi_40mg, 80mg 中文仿單_201801 (A3 排版) (new)-108-03-25(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025755&Seq=006&Type=9"
        },
        {
            "title": "13 中文仿單_EU_Edarbi 40mg+80mg tablet 2016Nov-A3_20180126 TFDA-107-02-01.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025755&Seq=005&Type=9"
        },
        {
            "title": "edarbi80bs(TW)鋁箔落板2-104-09-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025755&Seq=004&Type=8"
        }
    ]
}